These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18821183)

  • 1. Treatment of bipolar disorder: new perspectives.
    Alda M; Hajek T; Calkin C; O'Donovan C
    Ann Med; 2009; 41(3):186-96. PubMed ID: 18821183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinases as drug targets in the treatment of bipolar disorder.
    Catapano LA; Manji HK
    Drug Discov Today; 2008 Apr; 13(7-8):295-302. PubMed ID: 18405841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
    Manji HK; Moore GJ; Chen G
    Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME
    J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for bipolar disorder.
    Sanches M; Newberg AR; Soares JC
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):453-66. PubMed ID: 20486861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD; Zarate CA; Manji HK
    J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis and bipolar disorder.
    Daban C; Vieta E; Mackin P; Young AH
    Psychiatr Clin North Am; 2005 Jun; 28(2):469-80. PubMed ID: 15826743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
    Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
    Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision making in the treatment of mania.
    Perlis RH
    J Clin Psychiatry; 2008; 69 Suppl 5():16-21. PubMed ID: 19265636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between the PREP gene and lithium responsive bipolar disorder.
    Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
    BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder.
    Alda M; Grof P; Rouleau GA; Turecki G; Young LT
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
    Einat H; Chen G; Manji H
    Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.